Emerging Models of Biotech Investment @LifespanIO
Emerging Models of Biotech Investment  @LifespanIO
Uploaded June 2023 | Updated November 2026, 4 days ago
In this panel at Ending Age-Related Diseases 2022, Nathan Cheng of the Longevity Biotech Fellowship, Miri Polachek of Quadrascope, Laurence Ion of VitaDAO, Juliette Han of Cambrian Biopharma, and Alexandra Bause of Apollo Health Ventures come together to discuss the ways in which investment capital flows into the longevity biotech space. The panelists discuss the concentration of capital in specific companies and geographical areas along with the long-term viability of biotechnology accelerators.

FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
lifespan.io
facebook.com/lifespanio
instagram.com/lifespan.io

HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero
► Subscribe: youtube.com/user/LifespanIO
► Learn more, and help us: lifespan.io
#longevity #biotech #investment
Emerging Models of Biotech InvestmentFrom Physics To Aging Research -  Dr. Andrew Steele  - The Future Of Anti-aging BiotechnologyRegulatory Breakthroughs for Longevity and Blockchain Technology: Panel Discussion at EARD 2023Dr  Brad Stanfield on the Aging Interventions Currently AvailableRejuvenation Roundup Podcast - September 2021Digital Biomarkers and Games to Accelerate Geroscience | Keith Comito at Longevity Biomarker SummitVitaDAO - Decentralised Longevity Research - Tyler Golato | Lifespan.IOAging Clocks and Epigenetic Noise as Biomarker for Aging - Dr. Irina Conboy |  LRI Journal ClubJoin the Movement for Longevity with Lifespan.ioMichael Lustgarten on Optimizing Biologic Age - EARD 2022The BioAge Platform: From biomarkers to drug trials and back again: Eric Morgen, M.D. at EARD 2023OneSkin: Ask Me Anything Session at EARD 2023
Lifespan Research Institute |

Emerging Models of Biotech Investment

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER